Skip to main content
. 2021 Sep 4;8(1):48–64. doi: 10.1002/cjp2.235

Figure 3.

Figure 3

Distribution of HGPs in the external validation cohort of the MSKCC stratified for preoperative treatment status. (A) Distribution of HGPs in the chemo‐naïve cohort. (B) Distribution of HGPs in the preoperatively treated cohort. (C–E) Average observed proportion of replacement type HGP (C), desmoplastic type HGP (D), and pushing type HGP (E) in chemo‐naïve patients compared to preoperatively treated patients.